Related Experiment Video
Updated: Dec 9, 2025
10:15
Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
2.1K
Gut-Derived Protein-Bound Uremic Toxins
Amanda L Graboski1, Matthew R Redinbo2
1Department of Pharmacology, University of North Carolina, Chapel Hill, NC 27599-7365, USA.
Toxins
|September 16, 2020
Summary
Chronic kidney disease (CKD) is linked to harmful gut bacteria producing protein-bound uremic toxins (PBUTs) that dialysis cannot remove. Targeting the gut microbiota offers a promising CKD treatment strategy by reducing PBUTs.
Area of Science:
- Nephrology
- Microbiology
- Gastroenterology
Background:
- Chronic kidney disease (CKD) affects over 500 million globally, with rising mortality.
- Declining glomerular filtration rate leads to uremic toxin accumulation, increasing cardiovascular disease risk.
- Protein-bound uremic toxins (PBUTs) from gut microbiota are difficult to remove via dialysis.
Purpose of the Study:
- To review the origins and mechanisms of gut-derived PBUTs.
- To explore the link between kidney disease and gut dysbiosis.
- To discuss gut-targeted therapies for reducing PBUTs.
Main Methods:
- Literature review on PBUTs, gut dysbiosis, and therapeutic strategies.
- Analysis of bacterial taxa, gene regulation, and physiological consequences.
- Examination of emerging gut-targeted treatments for CKD.
Main Results:
- Gut microbiota produce harmful PBUTs contributing to CKD pathology.
- CKD is associated with gut dysbiosis, altering bacterial populations and toxin production.
- PBUTs have significant downstream physiological and neurological effects.
Conclusions:
- Targeting the gut microbiota is a viable therapeutic strategy for CKD.
- Reducing PBUTs through gut-targeted interventions can mitigate CKD complications.
- Interventions aimed at the gut microbiome hold promise for managing CKD patients.
Related Concept Videos
01:28Renal Drug Excretion: Tubular Secretion
589
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
589
01:15Drug Elimination by Renal Route: Tubular Secretion
3.1K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
3.1K
01:29Drug Distribution: Plasma Protein Binding
8.0K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
8.0K
01:29Acute Kidney Injury II: Pathophysiology
630
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
630
01:12Protein Absorption
748
Proteins in the gastrointestinal tract typically come from food, but they can also originate from disintegrated cells or secreted enzymes. In the stomach, the enzyme pepsin breaks down these proteins into polypeptides. The fragments then move into the duodenum as a semi-fluid mass called chyme. Pancreatic proteases, such as trypsin and chymotrypsin, and intestinal brush border enzymes like carboxypeptidases further dismantle the polypeptides into tripeptides, dipeptides, and free amino acids.
748
01:24Chronic Kidney Disease II: Clinical Manifestations
403
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
403